BioSign Flu A and B, Germaine Laboratories

Supplier: Germaine Laboratories

BSP-510-25 BSP-510-P
76143-706BX 603.57 USD
76143-706 76143-708
BioSign Flu A and B, Germaine Laboratories
Assays Immunological Assays

An In vitro rapid qualitative test that detects influenza type A & type B antigens directly from nasal swab, nasopharyngeal swab, and nasal aspirate/wash specimens.


  • Defferenciates between Inlfuenza Type A & B, on a sigle test device
  • Get results in 10–15 minutes
  • Each test device has built in controls
  • Each kit comes with external controls
  • Meets FDA preformance criteria for Influenza tests stated in code 21 CFR 866.3328


CLIA Complexity: Moderate complexity when used with Nasal Wash/Aspirate samples. CLIA Waived when used with nasal and nasopharyngeal swabs.


It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections, from the same specimen.

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR